Results 101 to 110 of about 5,881 (166)

A new therapeutic approach to <i>KRAS</i> mutant non-small cell lung cancer: the emerging role of exportin 1 inhibition. [PDF]

Transl Lung Cancer Res
von Itzstein MS, Gerber DE.
europepmc   +1 more source

Erratum: <i>KRAS</i> under attack: recent advances in targeted therapies involving G12C inhibitors and XPO1 inhibition. [PDF]

Transl Lung Cancer Res
Editorial Office.
europepmc   +1 more source

The Evolving Landscape of Systemic Therapy for Liposarcoma. [PDF]

Cancers (Basel)
Kim HK, Sarkari A, Chow WA.
europepmc   +1 more source

autoFISH: a modular toolbox for sequential single-molecule RNA FISH experiments. [PDF]

Commun Biol
Weber C, Defard T, Sturmach C, Lelek M, Laporte H, Mallick A, Gariboldi MI, Londoño-Vallejo JA, Walter T, Fouillade C, Bourg J, Mueller F.   +11 more
europepmc   +1 more source

Tandem Duplications in UBTF Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency. [PDF]

Blood Cancer Discov
Barajas JM, Phillips AH, Wang J, Thomas ME, Contreras L, Umeda M, Hiltenbrand R, Caldwell E, Walsh MP, Song G, Ezzell L, Churion K, Westover T, Xiong E, Rolle C, Moore J, Lott J, Radko-Juettner S, Kumar A, Qi W, Xu B, Papachristou EK, D'Santos CS, Ma J, Freeman BB, Janke LJ, Kriwacki RW, Klco JM.   +27 more
europepmc   +1 more source

Therapeutic Approaches Interfering with Nuclear Localization Signals: An Emerging Strategy for CNS-Related Diseases. [PDF]

Curr Neuropharmacol
Anyanwu M, Giannangeli M, Gianoncelli A, Ribaudo G.   +3 more
europepmc   +1 more source

Combination effect of Exportin 1 inhibitor (KPT-335) with doxorubicin or vincristine in canine lymphoma cell lines. [PDF]

J Vet Med Sci
Primarizky H, Kambayashi S, Baba K, Tani K, Okuda M.   +4 more
europepmc   +1 more source

Escorting mRNAs - the multifunctional and divergent roles of cap-chaperones in post-transcriptional gene expression. [PDF]

J Cell Sci
Embree CM, Borden KLB.
europepmc   +1 more source

Dual epigenetic and nuclear export inhibition by chidamide and selinexor in high grade B-cell lymphomas via survivin and PI3K/AKT inhibition. [PDF]

Clin Epigenetics
Lin J, Zhuang X, Jia S, Zhou H, Qin D, Zhou J, Chen B, Zhuang M, Xu B, Zha J.   +9 more
europepmc   +1 more source

Single-Agent Selinexor Versus Physician's Choice in Previously Treated Myelofibrosis: Results From the Phase 2 XPORT-035 Study. [PDF]

EJHaem
Grosicki S, Yimer H, Ayala R, Chen S, Liu H, Boyer F, Guglielmelli P, Brociner M, Sportoletti P, Mikala G, Tsirigotis P, Zhang J, Mark T, Chai Y, Ellero A, Lucchesi A.   +15 more
europepmc   +1 more source